HF
CATX icon

HRT Financial’s Perspective Therapeutics CATX Stock Holding History

HRT Financial’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12,217
Closed -$145K – 2305
2024
Q1 		$145K Buy
12,217
+10,190
+503% +$86.9K ﹤0.01% 1817
2023
Q4 		$8K Sell
2,027
-8,244
-80% -$23.2K ﹤0.01% 2094
2023
Q3 		$28K Buy
+10,271
New +$47.9K ﹤0.01% 2042
2023
Q1 		– Sell
-3,019
Closed -$7K – 2554
2022
Q4 		$7K Buy
+3,019
New +$9.95K ﹤0.01% 2249
2021
Q1 		– Sell
-6,295
Closed -$28K – 2733
2020
Q4 		$28K Buy
6,295
+4,434
+238% +$19.6K ﹤0.01% 1732
2020
Q3 		$10K Buy
+1,861
New +$12.1K ﹤0.01% 1806

Other funds holding CATX

CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return